Obesity Care: Experts Weigh In on Targeted Management
Released On
May 30, 2025
Expires On
June 30, 2026
Media Type
Internet
Completion Time
60 minutes
Specialty
Endocrinology, Obesity Medicine Specialists, Primary Care
Topic(s)
Obesity, Depression
This continuing education activity is provided by
This activity is supported by an educational grant from Currax Pharmaceuticals, LLC.
Credit Available
- Physicians — maximum of 1.00 AMA PRA Category 1 Credits™
- Physician Associates — 1.00 AAPA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
The intended audience for this activity is obesity medicine specialists and primary care providers involved in the management of patients with obesity.
Program Overview
Obesity is a chronic, multifactorial disease that disproportionately affects underserved populations such as postmenopausal women, individuals with depression, and those with nicotine addiction. These groups often experience biological and psychosocial challenges—including hormonal changes, dopamine pathway dysregulation, and stigma—that complicate effective weight management. Diagnosis and assessment should incorporate these patient-specific factors, along with an understanding of obesity as a disease rather than a personal failing. Management begins with comprehensive lifestyle interventions focused on diet and physical activity, but many patients benefit from pharmacotherapy, with several FDA-approved medications offering sustained weight loss when used alongside lifestyle changes. Optimal care requires a multidisciplinary team approach and shared decision-making to help foster personalized, equitable treatment. In this CE activity, expert faculty identify specific challenges to weight loss faced by persons from underserved populations and examine tailored management plans for these patients based on the clinical evidence for obesity medications.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify challenges to weight loss faced by persons from specific populations.
- Develop tailored management plans for patients from underserved populations based on the clinical evidence for obesity medications (OMs).
- Implement shared decision-making and interprofessional approaches to meet the specific needs of patients with obesity.
Activity Chair
Ethan Lazarus, MD, DABOM, DABFM, MFOMA
President and Owner, Clinical Nutrition Center
Senior Clinical Instructor, Department of Family Medicine
University of Colorado Anschutz
Former President, Obesity Medicine Association
Delegate, American Medical Association
Greenwood Village, CO
Faculty
Karlijn Burridge, PA-C, MFOMA
Founder and CEO: Gaining Health
Director of Clinical Education, Obesity: Healthy4Life
Naperville, IL
Sean N. Wharton, MD, PharmD, FRCPC
Assistant Professor
University of Toronto
Medical Director
Diabetes and Weight Management Centre
Wharton Medical Clinic
Toronto, Ontario, Canada
Accreditation Statement
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity.
Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 6/30/2026. PAs should only claim credit commensurate with the extent of their participation.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.
This enduring material is approved for 1 year from the date of original release, May 30, 2025, to June 30, 2026.
Disclosures of Conflicts of Interest
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
- Activity Chair and Faculty report the following relevant financial relationship(s)
Karlijn Burridge, PA-C, MFOM
- Advisor: Boehringer Ingelheim, Currax, Lilly, Novo Nordisk, Vivus
- Speaker Contracted by Ineligible Company: Lilly, Vivus
Ethan Lazarus, MD, DABOM, DABFM, MFOMA
- Advisor: Boehringer Ingelheim, Currax, Lilly, Novo Nordisk
Sean N. Wharton, MD, PharmD, FRCPC
- Advisor: AstraZeneca, Bausch Health Canada, Boehringer Ingelheim, Lilly, Novo Nordisk
- Independent Research Contractor: AstraZeneca, Boehringer Ingelheim, Lilly, Novo Nordisk
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.
Vindico Medical Education Staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Instructions for Participation and Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ or AAPA Category 1 CME credit certificate. Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement and Disclaimer
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2025 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
[email protected]
or call: 856-994-9400, ext. 614
Contact Information
For CME questions please contact: [email protected].